{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:07:58Z","timestamp":1779512878126,"version":"3.53.1"},"reference-count":197,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32570193"],"award-info":[{"award-number":["32570193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100125"],"award-info":[{"award-number":["32100125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD01906700"],"award-info":[{"award-number":["2025ZD01906700"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.antiviral.2026.106397","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:24:47Z","timestamp":1773825887000},"page":"106397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prospects for leveraging knowledge on ISG and NF-kB effector functions into anti-HBV therapies"],"prefix":"10.1016","volume":"249","author":[{"given":"Kaitao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8460-3893","authenticated-orcid":false,"given":"Yuchen","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106397_bib1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12306","article-title":"cGAS produces a 2\u2032-5\u2032-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106397_bib2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jhep.2013.10.021","article-title":"Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration","volume":"60","author":"Allweiss","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib3","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.4049\/jimmunol.163.9.5116","article-title":"Preferential role for NF-\u03baB\/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo","volume":"163","author":"Aronica","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib4","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.bbrc.2005.10.173","article-title":"A retrovirus restriction factor TRIM5\u03b1 is transcriptionally regulated by interferons","volume":"338","author":"Asaoka","year":"2005","journal-title":"Biochem. Bioph. Res. Co"},{"key":"10.1016\/j.antiviral.2026.106397_bib5","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"P Natl.Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2026.106397_bib6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature04596","article-title":"Toll-dependent selection of microbial antigens for presentation by dendritic cells","volume":"440","author":"Blander","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106397_bib7","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-Specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","author":"Boni","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2026.106397_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2015.02.026","article-title":"Interleukin 6 inhibits HBV entry through NTCP down regulation","volume":"481","author":"Bouezzedine","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2026.106397_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jir.2010.0120","article-title":"New insights into the role of RNase L in innate immunity","volume":"31","author":"Chakrabarti","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib10","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/ni.2090","article-title":"The ubiquitin ligase Peli1 negatively regulates T cell activation and prevents autoimmunity","volume":"12","author":"Chang","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib11","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.4049\/jimmunol.0803637","article-title":"NF-\u03baB1 p105 regulates T cell homeostasis and prevents chronic inflammation","volume":"182","author":"Chang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib12","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.4049\/jimmunol.1000317","article-title":"Regulation of the IL-21 gene by the NF-\u03baB Transcription factor c-Rel","volume":"185","author":"Chen","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.antiviral.2026.106397_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01824-16","article-title":"Matrix metalloproteinase 9 facilitates hepatitis B virus replication through binding with type I interferon (IFN) receptor 1 to repress IFN\/JAK\/STAT signaling","volume":"91","author":"Chen","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib14","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1080\/22221751.2020.1725398","article-title":"DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg. Microb. Infect."},{"issue":"17","key":"10.1016\/j.antiviral.2026.106397_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00442-20","article-title":"Interferon alpha induces multiple cellular proteins that coordinately suppress hepadnaviral covalently closed circular DNA transcription","volume":"94","author":"Cheng","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib16","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.29348","article-title":"Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages","volume":"66","author":"Cheng","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib17","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.2300569","article-title":"Liver-restricted type I IFN signature precedes liver damage in chronic hepatitis B patients stopping antiviral therapy","volume":"212","author":"Chua","year":"2024","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature12305","article-title":"Structural mechanism of cytosolic DNA sensing by cGAS","volume":"498","author":"Civril","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106397_bib19","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","article-title":"Epigenetic modulation in chronic hepatitis B virus infection","volume":"42","author":"Dandri","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.antiviral.2026.106397_bib20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106397_bib21","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/2211-5463.13382","article-title":"ISG20: an enigmatic antiviral RNase targeting multiple viruses","volume":"12","author":"Deymier","year":"2022","journal-title":"Febs Open Bio."},{"key":"10.1016\/j.antiviral.2026.106397_bib22","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1124\/pr.112.006171","article-title":"The therapeutic potential of modifying inflammasomes and NOD-Like receptors","volume":"65","author":"Di Virgilio","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2026.106397_bib23","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI70408","article-title":"Pegylated IFN-\u03b1 regulates hepatic gene expression through transient Jak\/STAT activation","volume":"124","author":"Dill","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2026.106397_bib24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1053\/j.gastro.2011.05.001","article-title":"5\u2032 triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice","volume":"141","author":"Ebert","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2026.106397_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104999","article-title":"Ponesimod suppresses hepatitis B virus infection by inhibiting endosome maturation","volume":"186","author":"Fauzyah","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jhep.2015.02.037","article-title":"The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection","volume":"63","author":"Gane","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.23011","article-title":"Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain","volume":"50","author":"Gao","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib28","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1126\/science.1240933","article-title":"Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses","volume":"341","author":"Gao","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106397_bib29","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/hep.29316","article-title":"Hepatitis B virus X protein-elevated MSL2 modulates hepatitis B virus covalently closed circular DNA by inducing degradation of APOBEC3B to enhance hepatocarcinogenesis","volume":"66","author":"Gao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting innate and adaptive immune responses to cure chronic HBV infection","volume":"156","author":"Gehring","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2026.106397_bib31","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0092-8674(02)00703-1","article-title":"Missing pieces in the NF-\u03baB puzzle","volume":"109","author":"Ghosh","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2026.106397_bib32","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000360946","article-title":"Molecular virology of hepatitis B virus and targets for antiviral intervention","volume":"57","author":"Glebe","year":"2014","journal-title":"Intervirology"},{"key":"10.1016\/j.antiviral.2026.106397_bib33","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.4049\/jimmunol.173.5.2913","article-title":"Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll\/IL-1 receptor domain-containing adaptor-inducing IFN-\u03b2 (TRIF)-dependent pathway in TLR signaling","volume":"173","author":"Gohda","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106397_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102741","article-title":"IFITM proteins: understanding their diverse roles in viral infection, cancer, and immunity","volume":"299","author":"Gomez-Herranz","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2026.106397_bib35","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1128\/JVI.75.6.2684-2691.2001","article-title":"Inhibition of hepatitis B virus replication by the interferon-inducible MxA protein","volume":"75","author":"Gordien","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102700","article-title":"The spectrum of APOBEC3 activity: from anti-viral agents to anti-cancer opportunities","volume":"83","author":"Green","year":"2019","journal-title":"DNA Repair"},{"key":"10.1016\/j.antiviral.2026.106397_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","author":"Guidotti","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2026.106397_bib38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.antiviral.2026.106397_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00771-17","article-title":"Activation of stimulator of Interferon genes in hepatocytes suppresses the replication of Hepatitis B virus","volume":"61","author":"Guo","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2026.106397_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11596-008-0103-z","article-title":"Cloning, eukaryotic expression of human ISG20 and preliminary study on the effect of its anti-HBV","volume":"28","author":"Hao","year":"2008","journal-title":"J. Huazhong U Sci.-Med."},{"key":"10.1016\/j.antiviral.2026.106397_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-\u03baB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2026.106397_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/cr.2011.13","article-title":"NF-\u03baB in immunobiology","volume":"21","author":"Hayden","year":"2011","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.antiviral.2026.106397_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13205","article-title":"Hepatitis B virus entry into HepG2-NTCP cells requires clathrin-mediated endocytosis","volume":"22","author":"Herrscher","year":"2020","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.antiviral.2026.106397_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105196","article-title":"JNJ-64794964 (AL-034\/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV\/HBV mice via non-cytolytic mechanisms","volume":"196","author":"Herschke","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hep.27793","article-title":"Liver inflammation abrogates immunological tolerance induced by Kupffer cells","volume":"62","author":"Heymann","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib46","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1172\/JCI0215254","article-title":"Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation","volume":"110","author":"Hilliard","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.antiviral.2026.106397_bib47","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106397_bib48","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1126\/science.1132505","article-title":"5\u2032-triphosphate RNA is the ligand for RIG-I","volume":"314","author":"Hornung","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106397_bib49","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but Interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"H\u00f6sel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib50","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/cr.2016.40","article-title":"Ubiquitin signaling in immune responses","volume":"26","author":"Hu","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/13543784.2021.1873275","article-title":"Safety, pharmacokinetics and pharmacodynamics of TQ-A3334, an oral toll-like receptor 7 agonist in healthy individuals","volume":"30","author":"Hu","year":"2021","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.antiviral.2026.106397_bib53","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ni.2573","article-title":"Intrahepatic myeloid-cell aggregates enable local proliferation of CD8+T cells and successful immunotherapy against chronic viral liver infection","volume":"14","author":"Huang","year":"2013","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.antiviral.2026.106397_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008338","article-title":"Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts","volume":"16","author":"Imam","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106397_bib55","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib56","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2015.08.008","article-title":"Immune-modulators to combat hepatitis B virus infection: from IFN-\u03b1 to novel investigational immunotherapeutic strategies","volume":"122","author":"Isorce","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2016.03.008","article-title":"Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus","volume":"130","author":"Isorce","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib58","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization","volume":"116","author":"Iwamoto","year":"2019","journal-title":"P Natl.Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2026.106397_bib59","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem. Bioph. Res. Co"},{"issue":"2","key":"10.1016\/j.antiviral.2026.106397_bib60","article-title":"Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection","volume":"6","author":"Janssen","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.antiviral.2026.106397_bib61","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jhep.2017.10.027","article-title":"Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B","volume":"68","author":"Janssen","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib62","article-title":"Clinical cure of chronic hepatitis B is dependent on activation and perpetuation of robust CD4 + T cell responses","author":"Jespersen","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.antiviral.2026.106397_bib63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2026.106397_bib64","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.4049\/jimmunol.181.9.6467","article-title":"The level of hepatitis B virus replication is not affected by protein ISG15 modification but is reduced by inhibition of UBP43 (USP18) expression","volume":"181","author":"Kim","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib65","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1096\/fj.01-0217","article-title":"Additive activation of hepatic NF-\u03baB by ethanol and HBX or HCV core protein: involvement of TNF-\u03b1 receptor I-independent and -dependent mechanisms","volume":"15","author":"Kim","year":"2001","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.antiviral.2026.106397_bib66","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001732","article-title":"Activities of endogenous APOBEC3s and uracil- DNA- glycosylase affect the hypermutation frequency of hepatitis B virus cccDNA","volume":"103","author":"Kitamura","year":"2022","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4049\/jimmunol.179.1.26","article-title":"Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages","volume":"179","author":"Kong","year":"2007","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106397_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112002","article-title":"Type I interferon\/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner","volume":"42","author":"Kong","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2026.106397_bib69","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1128\/JVI.01089-09","article-title":"Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets","volume":"83","author":"Koning","year":"2009","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.antiviral.2026.106397_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161313","article-title":"Antiviral efficacy and host innate immunity associated with SB 9200 treatment in the woodchuck model of chronic hepatitis B","volume":"11","author":"Korolowicz","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106397_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2025.110438","article-title":"HBx protein as a therapeutic target for functional cure of hepatitis B virus infection","volume":"604","author":"Kumar","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2026.106397_bib72","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of toll-like Receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","author":"Lanford","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2026.106397_bib73","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1124\/dmd.107.016907","article-title":"Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1\u03b2","volume":"36","author":"Le Vee","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2026.106397_bib74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/dmd.108.023630","article-title":"Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis Factor-\u03b1 or Interleukin-6","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.antiviral.2026.106397_bib75","doi-asserted-by":"crossref","first-page":"68179","DOI":"10.18632\/oncotarget.11907","article-title":"Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of Hepatitis B virus to impede the replication of HBV in vitro and in vivo","volume":"7","author":"Leong","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.antiviral.2026.106397_bib76","article-title":"Innate immune recognition in hepatitis B virus infection","volume":"16","author":"Li","year":"2025","journal-title":"Virulence"},{"key":"10.1016\/j.antiviral.2026.106397_bib77","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1136\/gutjnl-2017-314098","article-title":"Regulatory NK cells mediated between immunosuppressive monocytes and dysfunctional T cells in chronic HBV infection","volume":"67","author":"Li","year":"2018","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.antiviral.2026.106397_bib78","article-title":"Suppression of USP18 potentiates the Anti-HBV activity of Interferon alpha in HepG2.2.15 cells via JAK\/STAT signaling","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106397_bib79","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.4049\/jimmunol.1500839","article-title":"Kupffer cells support hepatitis B virus-mediated CD8T cell exhaustion via hepatitis B core Antigen-TLR2 interactions in mice","volume":"195","author":"Li","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib80","article-title":"Interferon and interferon-stimulated genes in HBV treatment","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib81","doi-asserted-by":"crossref","first-page":"424","DOI":"10.14218\/JCTH.2020.00046","article-title":"Macrophage phenotypes and hepatitis B virus infection","volume":"8","author":"Li","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41423-021-00801-w","article-title":"STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis","volume":"19","author":"Li","year":"2022","journal-title":"Cell. Mol. Immunol."},{"issue":"3","key":"10.1016\/j.antiviral.2026.106397_bib83","article-title":"Hepatitis B virus polymerase suppresses NF-\u03baB signaling by inhibiting the activity of IKKs via interaction with Hsp90\u03b2","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106397_bib84","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.4049\/jimmunol.1700540","article-title":"TLR2 stimulation strengthens intrahepatic Myeloid-Derived cell-mediated T cell tolerance through inducing kupffer cell expansion and IL-10 production","volume":"200","author":"Liu","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib85","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1002\/jmv.25718","article-title":"GP73 facilitates hepatitis B virus replication by repressing the NF-\u03baB signaling pathway","volume":"92","author":"Liu","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib86","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-Inducible Cholesterol-25-Hydroxylase broadly inhibits viral entry by production of 25-Hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2026.106397_bib87","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct.Tar."},{"key":"10.1016\/j.antiviral.2026.106397_bib88","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.4049\/jimmunol.2100618","article-title":"miR-146a maintains immune tolerance of kupffer cells and facilitates hepatitis B virus persistence in mice","volume":"208","author":"Liu","year":"2022","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.antiviral.2026.106397_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006296","article-title":"Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA","volume":"13","author":"Liu","year":"2017","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.antiviral.2026.106397_bib90","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/v9040069","article-title":"Identifying and characterizing interplay between Hepatitis B virus X protein and Smc5\/6","volume":"9","author":"Livingston","year":"2017","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.antiviral.2026.106397_bib91","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.antiviral.2026.106397_bib92","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jhep.2015.06.022","article-title":"Expression and functionality of Toll- and RIG-like receptors in HepaRG cells","volume":"63","author":"Luangsay","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106397_bib93","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1038\/s41598-018-23525-w","article-title":"Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes","volume":"8","author":"Lucifora","year":"2018","journal-title":"Sci. Rep.-Uk"},{"key":"10.1016\/j.antiviral.2026.106397_bib94","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear Hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106397_bib95","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/apt.17124","article-title":"TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and genetic polymorphism predicts PegIFN\u03b1 treatment response of HBeAg-positive chronic hepatitis B patients","volume":"56","author":"Luo","year":"2022","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2026.106397_bib96","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/JVI.01207-09","article-title":"Hepatitis B virus requires intact Caveolin-1 function for productive infection in HepaRG cells","volume":"84","author":"Macovei","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib97","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1074\/jbc.M109078200","article-title":"UBP43 (USP18) specifically removes ISG15 from conjugated proteins","volume":"277","author":"Malakhov","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2026.106397_bib98","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.emboj.7601149","article-title":"UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity","volume":"25","author":"Malakhova","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.antiviral.2026.106397_bib99","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1128\/JVI.01998-10","article-title":"Indoleamine 2,3-Dioxygenase mediates the antiviral effect of gamma interferon against Hepatitis B virus in Human hepatocyte-derived cells","volume":"85","author":"Mao","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib100","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","article-title":"Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression","volume":"177","author":"Martinez","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib101","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jhep.2014.12.026","article-title":"Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B","volume":"62","author":"Menne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib102","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1189\/jlb.0602325","article-title":"The many faces of macrophage activation","volume":"73","author":"Mosser","year":"2003","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.antiviral.2026.106397_bib103","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/v12030346","article-title":"The E3 ubiquitin ligase TRIM21 promotes HBV DNA polymerase degradation","volume":"12","author":"Mu","year":"2020","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.antiviral.2026.106397_bib104","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4161\/viru.23134","article-title":"The multiple faces of proteinkinase R in antiviral defense","volume":"4","author":"Munir","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.antiviral.2026.106397_bib105","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2026.106397_bib106","doi-asserted-by":"crossref","first-page":"17780","DOI":"10.1073\/pnas.0508913102","article-title":"Dynamics of hepatitis B virus clearance in chimpanzees","volume":"102","author":"Murray","year":"2005","journal-title":"P Natl.Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.antiviral.2026.106397_bib107","article-title":"TRIM26 positively affects hepatitis B virus replication by inhibiting proteasome-dependent degradation of viral core protein","volume":"13","author":"Nakaya","year":"2023","journal-title":"Sci. Rep.-Uk"},{"key":"10.1016\/j.antiviral.2026.106397_bib108","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","article-title":"Hepatitis B viruses: reverse transcription a different way","volume":"134","author":"Nassal","year":"2008","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106397_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169648","article-title":"The Smc5\/6 complex restricts HBV when localized to ND10 without inducing an innate immune response and is counteracted by the HBV X protein shortly after infection","volume":"12","author":"Niu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106397_bib110","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4T cells","volume":"327","author":"O'Shea","year":"2010","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.antiviral.2026.106397_bib111","article-title":"The NF-\u03baB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Csh Perspect.Biol."},{"key":"10.1016\/j.antiviral.2026.106397_bib112","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/imr.12033","article-title":"NF-\u03baB: roles and regulation in different CD4T-cell subsets","volume":"252","author":"Oh","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2026.106397_bib113","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2413","article-title":"TRIM family proteins and their emerging roles in innate immunity","volume":"8","author":"Ozato","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.antiviral.2026.106397_bib114","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3390\/v14040727","article-title":"IFITM3 interacts with the HBV\/HDV receptor NTCP and modulates virus entry and infection","volume":"14","author":"Palatini","year":"2022","journal-title":"Viruses-Basel"},{"issue":"11","key":"10.1016\/j.antiviral.2026.106397_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142599","article-title":"IL6 inhibits HBV transcription by targeting the epigenetic control of the nuclear cccDNA minichromosome","volume":"10","author":"Palumbo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106397_bib116","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/jgh.14986","article-title":"Antiviral activity of interferon-stimulated gene 20, as a putative repressor binding to hepatitis B virus enhancer II and core promoter","volume":"35","author":"Park","year":"2020","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.antiviral.2026.106397_bib117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2164-5-8","article-title":"Identification of a novel gene family that includes the interferon-inducible human genes 6-16 and ISG12","volume":"5","author":"Parker","year":"2004","journal-title":"BMC Genom."},{"key":"10.1016\/j.antiviral.2026.106397_bib118","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood-2006-10-051763","article-title":"Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression","volume":"110","author":"Peng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2026.106397_bib119","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5\u2032-phosphates","volume":"314","author":"Pichlmair","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106397_bib120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2026.106397_bib121","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00430-012-0267-9","article-title":"Host factors involved in hepatitis B virus maturation, assembly, and egress","volume":"201","author":"Prange","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib122","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.cell.2025.01.033","article-title":"A nucleosome switch primes hepatitis B virus infection","volume":"188","author":"Prescott","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2026.106397_bib123","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib124","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","article-title":"Control of hepatitis B virus at the level of transcription","volume":"17","author":"Quasdorff","year":"2010","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.antiviral.2026.106397_bib125","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/eji.200737916","article-title":"Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells","volume":"38","author":"Rajsbaum","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib126","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Rivi\u00e8re","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.634937","article-title":"The functional and antiviral activity of Interferon alpha-inducible IFI6 against hepatitis B virus replication and gene expression","volume":"12","author":"Sajid","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib128","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/ni1255","article-title":"Essential function for the kinase TAK1 in innate and adaptive immune responses","volume":"6","author":"Sato","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib129","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.196.Supp.202.7","article-title":"The antiviral molecule Mx1 positively regulates the induction of type I IFN in response to influenza infection","volume":"196","author":"Schattgen","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-Stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib131","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib132","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02289-22","article-title":"ABHD16A negatively regulates the palmitoylation and antiviral function of IFITM proteins","volume":"13","author":"Shi","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2026.106397_bib133","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01277-24","article-title":"Swine RNF5 positively regulates the antiviral activity of IFITM1 by mediating the degradation of ABHD16A","volume":"99","author":"Shi","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib134","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1002\/hep.30548","article-title":"Exosomal interferon-induced transmembrane protein 2 transmitted to dendritic cells inhibits interferon Alpha pathway activation and blocks anti-hepatitis B virus efficacy of exogenous interferon Alpha","volume":"69","author":"Shi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib135","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2026.106397_bib136","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1101\/gad.10.20.2600","article-title":"Smaug protein represses translation of unlocalized nanos mRNA in the Drosophila embryo","volume":"10","author":"Smibert","year":"1996","journal-title":"Gene Dev."},{"key":"10.1016\/j.antiviral.2026.106397_bib137","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/CM9.0000000000002617","article-title":"TRIM25 inhibits HBV replication by promoting HBx degradation and the RIG-I-mediated pgRNA recognition","volume":"136","author":"Song","year":"2023","journal-title":"Chin Med. J.-Peking"},{"key":"10.1016\/j.antiviral.2026.106397_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105107","article-title":"E3 ubiquitin ligase TRIM21 restricts hepatitis B virus replication by targeting HBx for proteasomal degradation","volume":"192","author":"Song","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib139","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949568","article-title":"Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20","volume":"22","author":"Stadler","year":"2021","journal-title":"EMBO Rep."},{"key":"10.1016\/j.antiviral.2026.106397_bib140","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1074\/jbc.M610138200","article-title":"Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells","volume":"282","author":"Stopak","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2026.106397_bib141","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I Interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106397_bib142","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2011.01088.x","article-title":"The noncanonical NF-\u03baB pathway","volume":"246","author":"Sun","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2026.106397_bib143","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.it.2008.07.003","article-title":"New insights into NF-\u03baB regulation and function","volume":"29","author":"Sun","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cr.2011.1","article-title":"A special issue on NF-\u03baB signaling and function","volume":"21","author":"Sun","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169631","article-title":"Antiviral efficacy and host immune response induction during sequential treatment with SB 9200 followed by Entecavir in woodchucks","volume":"12","author":"Suresh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2026.106397_bib146","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/cmi.2016.67","article-title":"Type I IFN augments IL-27-dependent TRIM25 expression to inhibit HBV replication","volume":"15","author":"Tan","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib147","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01872","article-title":"Identification of TRIM14 as a type I IFN-Stimulated gene controlling hepatitis B virus replication by targeting HBx","volume":"9","author":"Tan","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib148","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib149","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.28685","article-title":"Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection","volume":"64","author":"Thomsen","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105406","article-title":"TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity","volume":"207","author":"Tian","year":"2022","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib152","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission","volume":"44","author":"Tian","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2026.106397_bib151","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41586-025-09828-9","article-title":"Agonists for cytosolic bacterial receptor ALPK1 induce antitumour immunity","volume":"650","author":"Tian","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106397_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.656353","article-title":"Antiviral activity of Interferon Alpha-Inducible protein 27 against hepatitis B virus gene expression and replication","volume":"12","author":"Ullah","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2026.106397_bib154","article-title":"Interferon-stimulated gene (ISG12a) suppresses hepatitis B virus replication in Huh 7 cells line","volume":"36","author":"Ullah","year":"2024","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.antiviral.2026.106397_bib155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/MMBR.00024-13","article-title":"Mx proteins: antiviral gatekeepers that restrain the uninvited","volume":"77","author":"Verhelst","year":"2013","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.antiviral.2026.106397_bib156","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hep.30054","article-title":"Hepatitis B virus evasion from Cyclic guanosine monophosphate-adenosine monophosphate synthase sensing in human hepatocytes","volume":"68","author":"Verrier","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib157","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01198-25","article-title":"Interferon-induced miR-7705 modulates the anti-virus activity of cholesterol 25-hydroxylase","volume":"99","author":"Wang","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib158","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage M1-M2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib159","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.4049\/jimmunol.1201625","article-title":"Hepatitis B virus surface Antigen selectively inhibits TLR2 ligand-induced IL-12 production in Monocytes\/Macrophages by interfering with JNK activation","volume":"190","author":"Wang","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib160","article-title":"Hepatitis B e Antigen Inhibits NF-\u03baB Activity by Interrupting K63-Linked Ubiquitination of NEMO","volume":"93","author":"Wang","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib161","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jhep.2019.12.009","article-title":"Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication","volume":"72","author":"Wang","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib162","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41423-020-0431-x","article-title":"SAMD4 family members suppress human hepatitis B virus by directly binding to the Smaug recognition region of viral RNA","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib163","doi-asserted-by":"crossref","DOI":"10.3390\/v13081463","article-title":"Mechanism of hepatitis B virus cccDNA Formation","volume":"13","author":"Wei","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106397_bib164","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00677-22","article-title":"Dual-Role of Cholesterol-25-Hydroxylase in regulating hepatitis B virus infection and replication","volume":"13","author":"Wei","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2026.106397_bib165","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03095-24","article-title":"Depalmitoylase ABHD16A negatively regulates the anti-hepatitis B virus activity of IFITM1","volume":"13","author":"Wen","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.antiviral.2026.106397_bib166","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib167","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00468-24","article-title":"Tripartite motif-containing protein 21 is involved in IFN-\u03b3-induced suppression of hepatitis B virus by regulating hepatocyte nuclear factors","volume":"98","author":"Won","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib168","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1126\/science.1229963","article-title":"Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA","volume":"339","author":"Wu","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106397_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104824","article-title":"Hepatitis B virus cccDNA: formation, regulation and therapeutic potential","volume":"180","author":"Xia","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib170","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4828936","article-title":"Secreted interferon-inducible factors restrict hepatitis B and C virus entry in vitro","author":"Xia","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib171","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1053\/j.gastro.2018.07.057","article-title":"Development of direct-acting antiviral and host-targeting agents for treatment of hepatitis B virus infection","volume":"156","author":"Xia","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2026.106397_bib172","doi-asserted-by":"crossref","DOI":"10.3390\/v9010018","article-title":"Control of Hepatitis B virus by cytokines","volume":"9","author":"Xia","year":"2017","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.antiviral.2026.106397_bib173","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-\u03b3 and tumor necrosis Factor-\u03b1 produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2026.106397_bib174","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/vim.2022.0029","article-title":"Hepatitis B virus infection promotes M2 polarization of macrophages by upregulating the expression of B7x in vivo and in vitro","volume":"35","author":"Xiang","year":"2022","journal-title":"Viral Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib175","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1128\/JVI.00587-15","article-title":"Identification of cholesterol 25-Hydroxylase as a novel host restriction factor and a part of the primary innate immune responses against hepatitis C virus infection","volume":"89","author":"Xiang","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib176","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28749","article-title":"Mitochondrial HIGD1A inhibits hepatitis B virus transcription and replication through the cellular PNKD-NF-\u03baB-NR2F1 nexus","volume":"95","author":"Xie","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib177","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep.32614","article-title":"Alpha-kinase 1 (ALPK1) agonist DF-006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B","volume":"77","author":"Xu","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2024.199316","article-title":"Sulforaphane effectively inhibits HBV by altering Treg\/Th17 immune balance and the MIF-macrophages polarizing axis in vitro and in vivo","volume":"341","author":"Xu","year":"2024","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib179","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"10.1016\/j.antiviral.2026.106397_bib180","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.intimp.2016.06.015","article-title":"Hepatitis B virus antigens impair NK cell function","volume":"38","author":"Yang","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.antiviral.2026.106397_bib181","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/hep.30897","article-title":"Nuclear sensor interferon-inducible protein 16 inhibits the function of hepatitis B virus covalently closed circular DNA by integrating innate immune activation and epigenetic suppression","volume":"71","author":"Yang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2026.106397_bib182","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00328-23","article-title":"SLF2 interacts with the SMC5\/6 complex to direct hepatitis B virus episomal DNA to promyelocytic leukemia bodies for transcriptional repression","volume":"97","author":"Yao","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib183","first-page":"219","article-title":"Oncostatin M induces IFITM1 expression to inhibit hepatitis B virus replication via JAK-STAT signaling","volume":"17","author":"Ye","year":"2024","journal-title":"Cell Mol. Gastroenter."},{"key":"10.1016\/j.antiviral.2026.106397_bib184","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jhep.2016.12.018","article-title":"HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1\u03b2 production via suppressing the NF-\u03baB pathway and ROS production","volume":"66","author":"Yu","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib185","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01509-25","article-title":"Interferon alpha-inducible protein 27 (IFI27) inhibits hepatitis B virus (HBV) transcription through downregulating cellular transcription factor C\/EBP\u03b1","volume":"99","author":"Yu","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2026.106397_bib186","article-title":"HBx-induced HSPB1 is a potential therapeutic target owing to its modulation of HBV cccDNA and hepatic immune responses","author":"Yuan","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2026.106397_bib187","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-015-0056-4","article-title":"NF-\u03baB in inflammation and renal diseases","volume":"5","author":"Zhang","year":"2015","journal-title":"Cell Biosci."},{"key":"10.1016\/j.antiviral.2026.106397_bib188","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7150\/thno.20047","article-title":"A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.antiviral.2026.106397_bib189","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virs.2023.10.002","article-title":"LncRNA NKILA inhibits HBV replication by repressing NF-KB signalling activation","volume":"39","author":"Zhang","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.antiviral.2026.106397_bib190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molcel.2013.05.022","article-title":"Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING","volume":"51","author":"Zhang","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2026.106397_bib191","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature13801","article-title":"Human intracellular ISG15 prevents interferon-\u03b1\/\u03b2 over-amplification and auto-inflammation","volume":"517","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2026.106397_bib192","article-title":"Insights into hepatitis B virus DNA Integration-55 years after virus discovery","volume":"1","author":"Zhao","year":"2020","journal-title":"Innov.-Amsterdam"},{"key":"10.1016\/j.antiviral.2026.106397_bib193","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/cr.2015.108","article-title":"Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27","volume":"25","author":"Zheng","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.antiviral.2026.106397_bib194","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011382","article-title":"Hepatitis B virus hijacks TSG101 to facilitate egress via multiple vesicle bodies","volume":"19","author":"Zheng","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2026.106397_bib195","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/hep.30497","article-title":"A functional variant in ubiquitin conjugating Enzyme E2 L3 contributes to hepatitis B virus infection and maintains covalently closed circular DNA stability by inducing degradation of apolipoprotein B mRNA editing Enzyme catalytic subunit 3A","volume":"69","author":"Zhou","year":"2019","journal-title":"Hepatology"},{"issue":"28","key":"10.1016\/j.antiviral.2026.106397_bib196","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2026.106397_bib197","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/infdis\/jiw412","article-title":"Viral and host responses after stopping long-term nucleos(t)ide analogue therapy in HBeAg-Negative chronic hepatitis B","volume":"214","author":"zu Siederdissen","year":"2016","journal-title":"J. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:47:06Z","timestamp":1779511626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":197,"alternative-id":["S0166354226000562"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106397","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospects for leveraging knowledge on ISG and NF-kB effector functions into anti-HBV therapies","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106397"}}